questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines membranaires
Perforines
Hémolysines
Hémolysines : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hémolysines : Questions médicales les plus fréquentes",
"headline": "Hémolysines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hémolysines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-22",
"dateModified": "2025-04-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hémolysines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Perforines",
"url": "https://questionsmedicales.fr/mesh/D052899",
"about": {
"@type": "MedicalCondition",
"name": "Perforines",
"code": {
"@type": "MedicalCode",
"code": "D052899",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.695"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Hémolysines",
"alternateName": "Hemolysin Proteins",
"code": {
"@type": "MedicalCode",
"code": "D006460",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Vanesa Herlax",
"url": "https://questionsmedicales.fr/author/Vanesa%20Herlax",
"affiliation": {
"@type": "Organization",
"name": "Instituto de Investigaciones Bioquímicas de La Plata (INIBIOLP), CCT- La Plata, CONICET. Facultad de Ciencias Médicas. Universidad Nacional de La Plata, Argentina. Electronic address: vherlax@med.unlp.edu.ar."
}
},
{
"@type": "Person",
"name": "Li Li",
"url": "https://questionsmedicales.fr/author/Li%20Li",
"affiliation": {
"@type": "Organization",
"name": "Sichuan Animal Disease Prevention and Control Center, Chengdu 610041, China."
}
},
{
"@type": "Person",
"name": "Lucía Cané",
"url": "https://questionsmedicales.fr/author/Luc%C3%ADa%20Can%C3%A9",
"affiliation": {
"@type": "Organization",
"name": "Instituto de Investigaciones Bioquímicas de La Plata (INIBIOLP), CCT- La Plata, CONICET. Facultad de Ciencias Médicas. Universidad Nacional de La Plata, Argentina."
}
},
{
"@type": "Person",
"name": "Pablo J Schwarzbaum",
"url": "https://questionsmedicales.fr/author/Pablo%20J%20Schwarzbaum",
"affiliation": {
"@type": "Organization",
"name": "Instituto de Química y Fisico-Química Biológicas (IQUIFIB) \"Prof. Alejandro C. Paladini\", Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina."
}
},
{
"@type": "Person",
"name": "Lin Wei",
"url": "https://questionsmedicales.fr/author/Lin%20Wei",
"affiliation": {
"@type": "Organization",
"name": "Changchun University of Chinese Medicine, Changchun, 130117, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Treatment burden in multimorbidity: an integrative review.",
"datePublished": "2024-09-28",
"url": "https://questionsmedicales.fr/article/39342121",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12875-024-02586-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Redefining Multimorbidity in Older Surgical Patients.",
"datePublished": "2023-03-15",
"url": "https://questionsmedicales.fr/article/36919934",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/XCS.0000000000000659"
}
},
{
"@type": "ScholarlyArticle",
"name": "Goals of older hospitalized patients with multimorbidity.",
"datePublished": "2023-01-13",
"url": "https://questionsmedicales.fr/article/36637618",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s41999-023-00746-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Systemic Multimorbidity Clusters in People with Periodontitis.",
"datePublished": "2022-06-09",
"url": "https://questionsmedicales.fr/article/35678074",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/00220345221098910"
}
},
{
"@type": "ScholarlyArticle",
"name": "Patterns and Predictors of Multimorbidity in the Azar Cohort.",
"datePublished": "2023-01-01",
"url": "https://questionsmedicales.fr/article/37543916",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.34172/aim.2023.02"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines membranaires",
"item": "https://questionsmedicales.fr/mesh/D008565"
},
{
"@type": "ListItem",
"position": 5,
"name": "Perforines",
"item": "https://questionsmedicales.fr/mesh/D052899"
},
{
"@type": "ListItem",
"position": 6,
"name": "Hémolysines",
"item": "https://questionsmedicales.fr/mesh/D006460"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hémolysines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hémolysines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hémolysines",
"description": "Comment diagnostiquer une infection par hémolysines ?\nQuels tests sont utilisés pour détecter les hémolysines ?\nLes hémolysines sont-elles visibles sur une analyse sanguine ?\nQuels signes indiquent une hémolyse dans le sang ?\nPeut-on détecter les hémolysines par PCR ?",
"url": "https://questionsmedicales.fr/mesh/D006460?mesh_terms=Multimorbidity&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hémolysines",
"description": "Quels sont les symptômes d'une infection hémolytique ?\nComment l'hémolyse affecte-t-elle le corps ?\nY a-t-il des symptômes spécifiques aux hémolysines ?\nLes hémolysines provoquent-elles des réactions allergiques ?\nQuels signes cliniques sont associés à l'hémolyse ?",
"url": "https://questionsmedicales.fr/mesh/D006460?mesh_terms=Multimorbidity&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hémolysines",
"description": "Comment prévenir les infections par hémolysines ?\nLes personnes à risque doivent-elles prendre des précautions ?\nLes hémolysines peuvent-elles être évitées par l'alimentation ?\nLes mesures d'hygiène sont-elles suffisantes ?\nLes voyages à l'étranger augmentent-ils le risque d'hémolyse ?",
"url": "https://questionsmedicales.fr/mesh/D006460?mesh_terms=Multimorbidity&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hémolysines",
"description": "Quel traitement est recommandé pour une infection hémolytique ?\nComment traiter l'anémie causée par hémolyse ?\nLes corticostéroïdes sont-ils efficaces contre l'hémolyse ?\nY a-t-il des traitements préventifs pour les hémolysines ?\nQuand faut-il envisager une splénectomie ?",
"url": "https://questionsmedicales.fr/mesh/D006460?mesh_terms=Multimorbidity&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hémolysines",
"description": "Quelles complications peuvent survenir avec l'hémolyse ?\nL'hémolyse peut-elle entraîner des problèmes rénaux ?\nY a-t-il un risque de choc hypovolémique ?\nLes complications neurologiques sont-elles possibles ?\nComment gérer les complications liées à l'hémolyse ?",
"url": "https://questionsmedicales.fr/mesh/D006460?mesh_terms=Multimorbidity&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hémolysines",
"description": "Quels sont les facteurs de risque d'hémolyse ?\nLes personnes âgées sont-elles plus à risque ?\nLes maladies génétiques augmentent-elles le risque d'hémolyse ?\nLe stress peut-il influencer l'hémolyse ?\nLes transfusions sanguines augmentent-elles le risque d'hémolyse ?",
"url": "https://questionsmedicales.fr/mesh/D006460?mesh_terms=Multimorbidity&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par hémolysines ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic peut être établi par des tests sanguins et cultures bactériennes."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les hémolysines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests d'hémolyse sur milieux de culture et les tests sérologiques sont courants."
}
},
{
"@type": "Question",
"name": "Les hémolysines sont-elles visibles sur une analyse sanguine ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles ne sont pas directement visibles, mais peuvent être détectées par des tests spécifiques."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une hémolyse dans le sang ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une augmentation de la bilirubine et une diminution des globules rouges peuvent indiquer une hémolyse."
}
},
{
"@type": "Question",
"name": "Peut-on détecter les hémolysines par PCR ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la PCR peut être utilisée pour détecter les gènes codant pour les hémolysines."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une infection hémolytique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, fatigue, et signes d'anémie comme pâleur."
}
},
{
"@type": "Question",
"name": "Comment l'hémolyse affecte-t-elle le corps ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hémolyse peut entraîner une anémie, une jaunisse et des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux hémolysines ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs lombaires et des urines foncées peuvent survenir en cas d'hémolyse."
}
},
{
"@type": "Question",
"name": "Les hémolysines provoquent-elles des réactions allergiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent provoquer des réactions immunitaires, mais pas des allergies classiques."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés à l'hémolyse ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent tachycardie, hypotension et signes de choc dans les cas graves."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections par hémolysines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne hygiène et se faire vacciner contre les bactéries responsables."
}
},
{
"@type": "Question",
"name": "Les personnes à risque doivent-elles prendre des précautions ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées doivent éviter les contacts avec des sources d'infection."
}
},
{
"@type": "Question",
"name": "Les hémolysines peuvent-elles être évitées par l'alimentation ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée renforce le système immunitaire, mais ne prévient pas directement."
}
},
{
"@type": "Question",
"name": "Les mesures d'hygiène sont-elles suffisantes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont essentielles, mais doivent être combinées avec la vaccination pour une protection optimale."
}
},
{
"@type": "Question",
"name": "Les voyages à l'étranger augmentent-ils le risque d'hémolyse ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains pays présentent un risque accru d'infections hémolytiques, surtout sans vaccination."
}
},
{
"@type": "Question",
"name": "Quel traitement est recommandé pour une infection hémolytique ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques sont souvent prescrits pour traiter les infections causées par hémolysines."
}
},
{
"@type": "Question",
"name": "Comment traiter l'anémie causée par hémolyse ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des transfusions sanguines et des suppléments de fer peuvent être nécessaires."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils efficaces contre l'hémolyse ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent réduire l'inflammation et la destruction des globules rouges."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements préventifs pour les hémolysines ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination contre certaines bactéries peut aider à prévenir les infections hémolytiques."
}
},
{
"@type": "Question",
"name": "Quand faut-il envisager une splénectomie ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une splénectomie peut être envisagée en cas d'hémolyse auto-immune sévère et réfractaire."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'hémolyse ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'anémie sévère, la jaunisse et des défaillances organiques."
}
},
{
"@type": "Question",
"name": "L'hémolyse peut-elle entraîner des problèmes rénaux ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'hémolyse peut provoquer une insuffisance rénale aiguë en raison de la libération de toxines."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de choc hypovolémique ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une hémolyse massive peut entraîner un choc hypovolémique en raison de la perte de sang."
}
},
{
"@type": "Question",
"name": "Les complications neurologiques sont-elles possibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques peuvent survenir, notamment en cas d'anémie sévère prolongée."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées à l'hémolyse ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion nécessite un traitement rapide des infections et un suivi médical régulier."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'hémolyse ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des maladies auto-immunes, des infections et des antécédents transfusionnels."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru d'hémolyse en raison de la fragilité de leur système immunitaire."
}
},
{
"@type": "Question",
"name": "Les maladies génétiques augmentent-elles le risque d'hémolyse ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies génétiques, comme la sphérocytose, augmentent le risque d'hémolyse."
}
},
{
"@type": "Question",
"name": "Le stress peut-il influencer l'hémolyse ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut affaiblir le système immunitaire, augmentant ainsi le risque d'infections hémolytiques."
}
},
{
"@type": "Question",
"name": "Les transfusions sanguines augmentent-elles le risque d'hémolyse ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des transfusions incompatibles peuvent provoquer une hémolyse aiguë."
}
}
]
}
]
}
People living with multimorbidity experience increased treatment burden, which can result in poor health outcomes. Despite previous efforts to grasp the concept of treatment burden, the treatment burd...
This integrative review was conducted using the electronic databases MEDLINE, EMBASE, CINAHL, and reference lists of articles through May 2023. All empirical studies published in English were included...
Thirty studies were included in this review. Treatment burden consisted of four healthcare tasks and the social, emotional, and financial impacts that these tasks imposed on people living with multimo...
We developed an integrated map illustrating the relationships between treatment burden, the context of multimorbidity, people's resources, and the health outcomes. None of the existing measures includ...
DOI: https://doi.org/10.17605/OSF.IO/UF46V....
Multimorbidity in surgery is common and associated with worse postoperative outcomes. However, conventional multimorbidity definitions (≥2 comorbidities) label the vast majority of older patients as m...
We used Medicare claims for patients aged 66 to 90 years undergoing inpatient general, orthopaedic, or vascular surgery. Using 2016 to 2017 data, we identified all comorbidity combinations associated ...
Compared with conventional multimorbidity definitions, the new definitions labeled far fewer patients as multimorbid: general = 85.0% (conventional) vs 55.9% (new) (p < 0.0001); orthopaedic = 66.6% vs...
Our new multimorbidity definitions identified far more specific, higher-risk pools of patients than conventional definitions, potentially aiding clinical decision-making....
Patient-centered healthcare, with aligning treatment to a patients' goal, is recognized by experts as essential to improve healthcare for older patients with multimorbidity. Little literature exists o...
Older hospitalized patients (aged ≥ 70 years) were included in a prospective mixed-methods cohort study at the University Medical Centre Groningen, the Netherlands. Goals were assessed by a standardiz...
Four hundred and ninety-three older hospitalized patients (median age 75 (IQR 72-80), 64% male) were included, of which 223 patients presented with multimorbidity (45%). Goals mentioned most often wer...
No major differences were found in goals of older hospitalized patients with and without multimorbidity. However, the large proportion of patients mentioning disease-unrelated goals emphasizes the imp...
This study aimed to identify systemic multimorbidity clusters in people with periodontitis via a novel artificial intelligence-based network analysis and to explore the effect of associated factors. T...
The co-existence of chronic diseases (CDs), a condition defined as multimorbidity (MM), is becoming a major public health issue. Therefore, we aimed to determine the patterns and predictors of MM in t...
We evaluated the prevalence of MM in 15,006 (35-70-year old) subjects of the Azar Cohort Study. MM was defined as the co-existence of two or more CDs. Data on the subjects' socioeconomic status, demog...
The overall prevalence of MM was 28.1%. The most prevalent CDs, in decreasing order, were obesity, hypertension, depression, and diabetes. Obesity, depression, and diabetes were the most co-occurring ...
The reduction of MM is possible by promoting public health from an early age among people of various socioeconomic conditions. It is vital to offer the necessary health support to the aging population...
In patients with multimorbidity, healthcare providers follow various disease-specific guidelines. Besides the fact that simultaneous treatment of several chronic diseases can be intensive for the pati...
It is well recognised that haemodialysis patients have higher levels of multimorbidity, frailty and sarcopaenia. This review examines the current understanding of the three concepts in relation to the...
Multimorbidity in on the rise in the general population and this is one of the contributing factors to higher rates of chronic kidney disease, progression to end-stage renal disease and multimorbidity...
Effective public health policies are likely to have an impact on reducing the prevalence of multimorbidity and the development of end stage renal disease. Future research is required to develop interv...
Invited commentary on Letter: Acta Biomed 2022; Vol. 93, N. 2: e2022136 DOI 10.23750/abm.v93i2.12855 https://mattioli1885journals.com/index.php/actabiomedica/article/view/12855....
The challenge of multimorbidity, the occurrence of multiple medical conditions, lies in its complexity, considering their type and severity, their interactions, and the patient's social status and cha...
Multimorbidity, also known as multiple long-term conditions, leads to higher healthcare utilisation, including hospitalisation, readmission, and polypharmacy, as well as a financial burden to families...